Introduction
Beginning in the early 1970s, Per Pinstrup-Andersen conducted pioneering work into the links between agricultural research and development (R&D) and its consequences for nutrition and health outcomes of the poor.
1 In this paper we revisit those links in the context of two twenty-first century conundrums. First, while many of the world's poor remain undernourished, paradoxically, growing numbers of people from a very broad range of income and social strata are overweight or obese. Second, rates of investment in agricultural research are slowing in many countries in spite of continuing high social rates of return to the investments, a trend toward higher food prices, and slowing rates of farm productivity growth in many countries.
It is widely acknowledged that public agricultural R&D has been a crucial policy for creating the era of agricultural abundance that now appears to be in jeopardy. 2 To what extent is this abundance that has saved and improved many millions of lives also responsible for the rise of obesity? What is the nature of the trade-offs between health and nutrition problems arising from increasing food abundance (or rising incomes) versus health and nutrition problems arising from food scarcity (or poverty)? What are the implications for policy? Should we use agricultural R&D as an instrument of public health policy or other dimensions of social policy?
One view is that agricultural R&D should be revitalized and refocused to enhance farm productivity growth and make food more abundant and cheaper, and thereby address problems of 1 See, for example, Pinstrup-Andersen, de Londono and Hoover (1976) , Pinstrup-Andersen (2007) , Herforth, Jones and Pinstrup-Andersen (2012) , and Pinstrup-Andersen (2013).
2 For example, Easterbrock (1997) commented "Though barely known in the country of his birth, elsewhere in the world Norman Borlaug is widely considered to be among the leading Americans of our age ... Norman Borlaug has already saved more lives than any other person who ever lived ... Borlaug is responsible for the fact that throughout the postwar era, except in sub-Saharan Africa, global food production has expanded faster than the human population, averting the mass starvations that were widely predicted-for example, in the 1967 best seller Famine-1975 ! [the authors observed that] The form of agriculture that Borlaug preaches may have prevented a billion deaths." poverty and food security that are foreseen through to 2050 (Ravallion 2013) . Some suggest that we should ramp up research on fruits and vegetables at the expense of research on cereals and livestock products as a way of improving nutritional outcomes. Others may suggest that R&D should emphasize other dimensions of nutrition such as developing staple foods that are richer in specific micronutrients. In this paper we explore these competing ideas. We present up-to-date evidence on trends in agricultural research investments, productivity, and prices, connect them to patterns of human health outcomes around the world, and draw inferences for public R&D policy.
Economics and politics of agricultural R&D policy
Since around the middle of the 19 th Century, the application of science to agricultureincreasingly by way of targeted investments in R&D-has released lots of labor and other (especially land) resources from the production of food and other agricultural outputs (Ruttan 1982) . In 1800, before this R&D-induced process of agricultural transformation got underway, the planet's population was around 980 million people, most of whom lived and worked in agriculture (an estimated 75-80 percent of the working population of the time earned its livelihood in agriculture, see Bairoch 1988) . Over two centuries later, in 2010, the world's population had increased sevenfold and now-although a significant number of people still live a hand-to-mouth existence, growing much or all of the food they consume-more than half the world's population lives in urban areas while less than 40 percent of the working population earn their livelihoods from agriculture. 3 Land used in agriculture worldwide increased by much less than global population, such that in 2010 agriculture had to feed 1.41 persons per hectare compared with just under one person in 1800.
The fact that the Malthusian nightmare has been largely averted is attributable in great part to remarkable gains in agricultural productivity achieved through technological change.
Over the past 50 years, even though the world's population more than doubled and per capita incomes grew, compounding the growth in demand, the global food supply grew even faster.
Real output from agriculture grew by 2.7 percent per year (equivalent to a 259 percent increase A great many studies have found consistently high rates of return to the investments in public and private agricultural R&D (e.g., see Rao, Hurley and Pardey 2012) . Double-digit benefit-cost ratios are typical. The benefits have accrued through enhanced farm incomes, lower costs of food production, reduced stress on the natural resource base, and the release of resources for other uses. The consequences can be seen in many measures of improved health and welfare, especially of the poor, though identifying the details of the complex pathways and attributing consequences among sources is challenging.
A reversal of fortune?
Recent trends are less salutary. By various measures growth rates of agricultural productivity have systematically slowed for most countries and for the world as a whole since 1990 if not sooner-for example, since 1960 cereal yields have grown essentially linearly, which implies a progressive slowdown in proportional growth . This productivity slowdown-along with other factors-is reflected in prices (e.g., see Alston, [ Figure 1 : Trends in prices and yields of cereals, 1961-2012] In the coming 50 years, significant growth in agricultural production will be necessary to meet the increasing food demands of a growing and richer (as well as aging and urbanizing) world population plus the ongoing but likely less-pronounced growth in the demand for bioenergy feedstocks (Pardey et al. 2014a) . As in the past 50 years, much of this growth in production will have to come from increased productivity given a tightening of the scope for expanding the agricultural use of land and water. But simply sustaining current (let alone restoring the higher past) rates of productivity growth will require greater effort in view of the emerging challenges of climate change and the attendant implications for changing the abiotic (i.e., drought, temperature and so on) and biotic (i.e., pest and disease) stresses on agricultural plants and animals.
4 Jorgenson and Griliches (1967) showed that under certain conditions (constant returns to scale and perfect competition), the ratio of the price index for inputs to the price index for output (the inverse of what is sometimes referred to as the farmers' terms of trade) is exactly equal to the primal measure of total factor productivity, TFP (or more precisely, in practice, multi-factor productivity, MFP). See also Alston, Babcock and Pardey (2010, pp. 456-457) .
The contemporary trends in science policy run contrary to these arguments. In spite of the adverse implications of slowing productivity growth (e.g., , and even though rates of return to agricultural research are demonstrably very high, we have seen a slowdown in R&D spending growth and a diversion of funds away from farm productivity enhancement, especially in the richest countries (Pardey, Alston and Chan-Kang 2013) . China now spends more than the United States on public agricultural R&D, and the low-and middleincome countries are collectively outspending the group of high-income countries. These patterns seem to indicate that in the high-income countries, at least, governments are not much concerned about agricultural productivity, in spite of evidence of very large benefits from farmproductivity enhancing agricultural R&D.
Why is it so? Commonly, policymakers in the high-income countries in particular appear to discount the evidence on the returns to research, which demonstrate a persistent gross underinvestment, or to misunderstand the implications-or perhaps they simply care more about other things. In the 1980s some people said that investing in agricultural R&D was wasteful-at least in the high-income countries-because we were already overproducing farm commodities.
This view reflected a misunderstanding of the fact that the important consequence of research has been to save resources on infra-marginal production, and make food cheaper to produce, such that research is valuable even if a commodity is in surplus, which is itself an unusual (government created) phenomenon. A more contemporary version of the same sentiment relates to obesity. Some say we already produce and consume too much of certain kinds of food-such as corn and other grains and livestock products-and we should cut back or cease undertaking R&D that enhances productivity of those foods in favor of R&D that promotes productivity in, and thus consumption of, foods such as fruits and vegetables that are perceived as being healthier and less fattening (e.g., Popkin 2010) . In this paper we seek to provide more clarity on the interpretation of traditional measures, along with some less-traditional measures of the consequences of agricultural R&D for the poor.
What's agricultural productivity worth worldwide?
What might the world be like today if our forebears had opted not to make the research investments that enabled the Green Revolution and other changes in agriculture over the past 50 The benefits in column 5 are distributed reasonably congruently with total population in column 3-food is produced to a great extent within the countries and regions within which it is consumed-such that the benefits per capita in column 6, which average $299 for the world as a whole, are reasonably comparable among regions once we set aside the very low measure for Sub-Saharan Africa ($105). However, when we express these benefits per capita relative to GDP per capita from column 5, in column 6 we see that the benefits from agricultural productivity growth are much more important as a share of income for lower-income countries, even if the benefits per capita per se may be smaller than in the high-income countries. These benefits represent only 0.8 percent of GDP for the high-income countries but a more significant 3.2 percent of GDP in 2009 for the world as a whole, and well over 5 percent of GDP for the middleincome countries and the low-income countries. The ranking of countries now depends on both their growth rates of productivity and the country-specific relative importance of agriculture in the economy. Setting aside countries (mainly those in sub-Saharan Africa) where measured 6 For comparison, in 2009 the world as a whole spent around $53 billion (2005 prices) on public and private agricultural and food R&D, roughly one-third of which was performed by private firms, and two-thirds was conducted in the public sector by national agricultural research agencies (Pardey et al. 2014b) . In that year an additional $530 million (2005 prices) was invested in the international agricultural research centers of the Consultative Group on International Agricultural Research, CGIAR. 7 The use of such approximations to measure the benefits from innovation attributable to research-induced productivity growth can be traced back at least as far as Griliches (1958) . This application has three elements of awkwardness. First, in principle, we would prefer to apply the "k" factor to the gross value of production (GVP), whereas AgGDP is a value-added measure. The discrepancy between AgGDP and GVP is likely to vary systematically with per capita incomes, with AgGDP representing a smaller share of GVP in the higher-income countries. Second, public and private agricultural R&D are responsible for only a fraction of the total growth in TFP, and this difference also will vary systematically among countries depending on the stage of development. Third, the measures of TFP growth are likely to be more accurate for the higher-income countries, if only because they are more likely to have appropriately detailed data available in suitably long series.
agricultural TFP failed to grow over the past half century, Figure 2 clearly illustrates how the relative economic importance of productivity growth in agriculture increases as per capita incomes decline. 8 This pattern of relative importance of gross benefits from agricultural productivity growth helps to account for the observation that policymakers in the high-income countries appear to be relatively unconcerned with farm productivity nowadays.
[ Figure 2 : The comparative economic importance of agricultural productivity growth, 2009] Of course, the benefits from agricultural productivity growth are not distributed uniformly among households within a country-especially when we take into account that, through international commodity trade, productivity growth in one country can affect prices in another. Agricultural technology induces changes in the distribution of income among and within households, through a multitude of direct and indirect effects and the optimizing responses of the households. Even if agricultural technology has no direct effect on household incomes, it affects food security or poverty through its effects on the price of food. Benefits accrue to (farm) households both (a) through reductions in the costs of production (for those that adopt the technology), and (b) through reductions in the net costs of food purchases (the difference between their expenditure on food consumption and the value of their production)
resulting from the fall in price. For food deficit households, the fall in price means a benefit; for food surplus households, it means a loss. In addition to these two direct sources of benefits, households may gain (or lose) indirectly from induced adjustments in factor markets in which 8 Productivity estimates from Fuglie et al. (2012) indicate that 24 (out of 155) countries for which we have corresponding agricultural GDP estimates failed to sustain positive TFP growth in agriculture since 1961, and that 13 (55 percent) of those countries were in sub-Saharan Africa. In turn these 13 countries had 2009 research intensity ratios (i.e., the share of agricultural R&D spending relative to agGDP) of just 0.5 percent (compared with a global average of 1.0 percent), and one third of these countries were spending less in inflation-adjusted terms on public agricultural R&D in 2009 than they were in 1961.
they participate as well as broader, general equilibrium impacts (e.g., Alston, Martin and Pardey 2014) . A large and growing fraction of the world's poor are nonfarm rural or urban dwellers whose only direct economic benefits from agricultural productivity growth will be through the impacts on food prices-whether as a result of changes in technology in their own country or elsewhere in the world. If we were to revert to 1961 farm productivity patterns today, other things held constant, farm commodity prices would be much higher than they were in 1961 given the much greater population and higher per capita incomes. For the very poor who are net buyers of farm products, the real income consequences of such an increase in prices would be very serious-devastating for many-as illustrated by the events following the commodity price spike in 2007.
To illustrate the regressive, negative real income consequences of an increase in food prices, Figure 
(Mal)nutrition, health and agriculture
Quantifying the relationship between R&D spending and agricultural productivity growth is tough enough. Clarifying the complex, cloudy, and sometimes confounding associations between agricultural production and productivity growth (and the commodity composition of that growth) and the human nutrition and health outcomes associated with food consumption is especially daunting, doubly so when drawing on aggregate data. Here we summarize some of consumers demand more services associated with food as well as other nonfood items that also have larger elasticities of demand with respect to total expenditure. Thus, for the poor people in poor countries who typically eat less processed and more home-prepared foods, commodity costs represent a larger share of their food budget, which itself represents a comparatively large share of the total budget. the scholarship linking various anthropometric attributes to nutrition and other factors (from a broad historical perspective), complemented by some of the available empirical evidence on global poverty, malnutrition and mortality. This provides a basis for beginning to build the conceptual and empirical bridges linking R&D, agricultural productivity and anthropometric indicators to help calibrate thinking about the appropriate policies and priorities regarding agricultural R&D over the decades ahead.
Anthropometric angles on agriculture, food and health
Cutler, Deaton and Lleras-Muney (2006) critically assessed the reasonably extensive literature regarding the determinants of mortality, including its historical decline and the prevalence of premature death in today's poor countries. They singled out improvements in nutrition and public health along with urbanization, the avoidance of disease, and modern medical, especially therapeutic, treatments as putative factors accounting for the decline in mortality over time. Drawing on the work of Fogel (1997) , Costa and Steckel (1997) , and others, they concluded that the century of mortality decline in Europe (and presumably in other places with similar incomes) that began in the middle of the 18th Century owed much to improvements in nutrition and economic growth. 12 This transitioned to a second phase beginning in the late 19th Century in which "… improvements in public health [including sanitation, filtered and chlorinated water, and mass vaccinations] mattered more" (Cutler, Deaton and Lleras-Muney 2006, p. 106), followed by a third phase, from the 1930s onwards, in which medical treatments dealing with diseases and injuries became a primary driver of reduced mortality.
Diseases and mortality
A host of anthropometric indicators are used to reveal different dimensions of human health: including height and weight (for age), body mass and other under-and over-nourished (e.g., obesity) related metrics such as the prevalence of nutrition-related diseases, hypertension, diabetes, blindness, cognitive ability, and so on. One of the most prevalent and arguably amongst the most compelling indicators is average life-expectancy-at-birth ( Figure 5 ). An association between life expectancy and per capita income over the long term is revealed in Figure 6 . The comparatively tight clustering of life expectancies in 1800 is once again evident in Figure 6 , Panel a; an era when cross-country differences in per capita income were also muted, most of that income was being earned in agriculture, and before the advent of modern sanitation, public health and science-based medical services anywhere in the world.
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Comparing Panel a with Panel b in Figure 6 , over two centuries later, in 2010, two key developments are evident. At any particular level of income, people live substantially longer than they did in the past. Second, the spread in life expectancies among countries is now more pronounced and appears to be positively, but not exclusively, related to per capita income.
While per capita income affects food consumption along with access to and use of education, information, sanitation, medical and other health-promoting goods and services, many of these factors affect life expectancy in different ways in different phases of a person's life (fetal, immediate post-natal, and later in life). These various and variable inter-temporal effects linking per capita income over a lifetime both directly and indirectly to the timing of mortality thus confound the relationship between the data on average life-expectancy-at-birth in a specific year and contemporaneous measures of average per capita income. Preston (1975 Preston ( , 1980 Preston ( and 1996 , for example, estimates that increases in income alone account for only 20 percent of the increase in life expectancy.
[ Figure 6 : Per capita income and average life expectancy at birth, 1800 and 2010] Mortality is an affliction that affects us all, sooner or later. However, the notional causes of mortality vary across countries, and over time within countries. WHO (2011) data indicate that in 2008, a total of 50 million people died, and most (70 percent of the global total) of those deaths occurred in the middle-income countries. The generally older and smaller populations of the richer countries had a total of 7.2 million deaths (14 percent of their total), while 7.8 million people (15.5 percent) died in the increasingly populous but younger populations of the lowincome countries. Figure 7 summarizes the numbers, shares and rates of death according to 16 The flush toilet was first popularized (initially in Britain and Europe) around the middle of the 19 th Century; the initial clinical application of penicillin in the early 1940s ushered in the modern era of antibiotics; and anti-retroviral treatments for HIV-infected people followed from scientific evidence on the viral dynamics of this disease in 1996.
various categories of diseases and injuries attributed as the cause of death. Death rates (i.e., the number of deaths per 100,000 people) generally increased as per capita incomes decreased, with 1,014 deaths per 100,000 people in low-income countries, 51 percent higher than the 672 rate of death in high-income countries. Average death rates of upper-middle-income countries were similar to those of high-income countries, whereas average death rates in the lower-middleincome countries fell between the low and upper-middle income averages.
[Figure 7: Global deaths by category of disease and injury, 2008]
Higher-income countries tend to have older populations, while the populations in lowerincome countries are generally younger. Figure 8 stratifies countries into several per capita income and age cohorts. Cancers led to many more deaths in high-and upper-middle-income countries compared with the rest of the world, and most of those deaths involved the elderly.
Most of the deaths attributed to cardiovascular diseases and diabetes also occurred in people over 60 years of age, but most of these deaths occurred in the middle-income countries. Around 81 percent of the worldwide deaths attributable to HIV, tuberculosis, and malaria occurred in the lower-middle-and low-income countries and largely afflicted those less than 14 years of age.
The lower-middle-and low-income countries also accounted for 90 percent of the worldwide deaths attributed to maternal, perinatal, nutritional and diarrheal diseases, and within the lowincome countries 19 percent of all deaths were associated with this group of diseases. Moreover, most of the deaths occurred among the young: 7.9 million children 14 years of age or less died from these diseases in lower-middle-and low-income countries, 0.96 million in the uppermiddle-and high-income countries. A recent analysis by Black et al. (2013) estimated that in 2011, 3.1 million children under the age of five died from undernutrition, accounting for 45 percent of total child deaths worldwide in that year. . High-and upper-middle-income countries look similar on this score, where diseases associated most commonly with over nutrition (i.e., cerebrovascular, diabetes and hypertensive heart disease) accounted for over 95 percent of the nutritionally related deaths in both groups of countries. In stark contrast, deaths from disease associated with contaminated food or undernutrition (i.e., diarrheal disease, prematurity and low birth weight, and "nutritional" diseases in WHO parlance) accounted for 31 percent and 48 percent of the deaths in lowermiddle-and low-income countries respectively. Over 63 percent of those "nutritional" related deaths were associated with protein-energy malnutrition (Panel d).
[Figure 9: Deaths caused by nutrition-related diseases, 2008] Obesity
The worldwide prevalence of obesity has increased rapidly and the related health concerns are priority issues for governments and the medical community worldwide (e.g., see WHO, 1997; International Obesity Task Force, 2005) . WHO (2013) data indicate that over onefifth of the population in high-income countries was obese (BMI values of 30kg/m2 or higher) in
2008.
17 The respective low-and middle-income shares were 3.2 and 10.1 percent respectively, but these averages mask substantial regional differences. For instance, only 4.2 percent of the people living in the Asia and Pacific region were deemed obese (and 7.6 percent of those living in sub-Saharan Africa) versus 23.6 percent of the population in the Latin America and Caribbean region.
In addition to the substantial personal costs they bear, obese and overweight people generate large additional direct and indirect health-care expenses (for instance, Parks, Alston and Okrent 2012 estimated that $181.1 billion or 16.6 percent of U.S. public medical expenditures in 2009 could be attributed to obesity). However, the appropriate policy, if any, for reducing obesity is not clear. Some potential policies work through the use of food prices as incentives.
Non-economists and economists alike appear to take the view that food prices should matter for consumption choices and the resulting obesity outcomes. Such thinking underpins various proposals for introducing tax or subsidy policies to discourage less-healthy and encourage morehealthy consumption choices, and some such proposals work through prices of farm commodities used to make food. Economic studies have consistently found that farm subsidies have had negligible impacts on U.S. obesity patterns; however some have suggested that public agricultural research and development (R&D) may have contributed to obesity by making farm commodities cheaper and more abundant.
18

Agricultural R&D as obesity policy
In real terms, the prices of major agricultural commodities have fallen by 50 percent or more since 1950, and agricultural R&D has been credited as a primary engine for those changes.
In turn, these farm productivity gains have been reflected in lower prices of retail food products (e.g., Lakdawalla, Philipson and Bhattacharya 2005; Coble 2007, 2008) . Lower food prices alone would be sufficient to encourage some increases in food consumption, but relative prices also moved in favor of the production and consumption of "unhealthy" foods that use field crops and livestock as ingredients, potentially making matters worse.
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A reasonable question is whether society would have been served better by a different pattern of private and public investments in agricultural R&D and technologies. 20 A corollary question, looking forward, is whether the agricultural research portfolio should be tilted more in favor of healthy foods, and away from less-healthy foods. 21 This is a complex question.
Pertinent issues are (a) the extent to which it is possible to achieve public purposes related to obesity by changing the agricultural R&D portfolio, (b) the opportunity cost of conventional research benefits that must be foregone, through changing the mixture of research investments, in exchange for a given reduction in the prevalence of obesity, and (c) the extent to which these gains might be achieved at lower cost through the use of other policy instruments, more directly targeted at the problem of obesity (see Appendix A). Economic assessments consistently show remarkably high rates of return to public investments in agricultural research (e.g., Alston et al. 2011 , report benefit-cost ratios in the range of 20:1 or 30:1 for the United States). These high benefit-cost ratios indicate that the total R&D portfolio is too small. An implication is that 19 Some authors have argued that this is because productivity gains for fruit and vegetable farm commodities have been somewhat slower than those for field crops and livestock (e.g., see Drewnowski and Darmon 2005 , Drewnowski and Specter 2004 , Popkin 2010 , but the detailed empirical analysis by Alston and Pardey (2008) does not support that view. 20 For example, Popkin (2010) attributes the rise in U.S. obesity to a pervasive role of government in promoting the production and consumption of animal products, and a few grains and oilseeds, at the expense of other more healthy foods, both through direct subsidies and through public agricultural R&D. Many other writers on food and nutrition policy have echoed these sentiments. Like Popkin, these writers never clearly state the full details of the relevant counterfactual, however. (Glickman et al. 2012) recommended that the American Congress and the Administration "should ensure that there is adequate public funding for agricultural research and extension so that the research agenda can include a greater focus on supporting the production of foods Americans need to consume in greater quantities according to the Dietary Guidelines for Americans" (p. 435). Such recommendations have also been echoed within the medical community (e.g., Grandi and Franck 2012) as well as by policymakers (e.g., Whitehouse Taskforce on Childhood Obesity Report to the President 2010).
distorting that already-too-small portfolio with a view to achieving obesity objectives might impose very large social opportunity costs.
Recent empirical work supports that view in the case of the United States. Alston, Okrent and Parks (2013) adult body weight. Similar results were found for other simulated changes in research spending.
These measures suggest that changing agricultural R&D spending is an ineffective and very inefficient way to reduce obesity-perhaps more so when we consider the R&D lags which mean that any change in policy today might not begin to substantially affect prices, consumption, and obesity for 20 or 30 years.
Other policies are likely to be more effective and efficient as obesity policies. These could include policies to reduce the distortions from insurance pools and free public health care, educational programs, or other policies to encourage and facilitate healthier individual choices about food and exercise, including taxes and subsidies. 22 Much has been written about the use of taxes on farm commodities (e.g., corn), particular nutrients (e.g., sugar, fat), or particular foods (e.g., sugar-sweetened beverages) to combat obesity, and some jurisdictions have enacted policies in this genre. Okrent and Alston (2012) evaluated such policies using the same model as used by Alston, Okrent, and Parks (2013) ; hence, the findings are directly comparable. Okrent and Alston (2012) found that taxes on food based on its fat content, sugar content, or total caloric content would yield net social benefits. With these policies-unlike changing R&D spending to reduce obesity-the benefits from reduced excess health-care spending costs would outweigh the reduction in private benefits from consumption and production of food. Specifically, they found that (unlike the research policies which would entail a social cost to reduce obesity) the tax policies they evaluated would yield a net social benefit per pound reduction in U.S. average adult body weight (fat tax, $1.31 per pound of body weight; taxing all food, $1.54 per pound of body weight; sugar tax $1.73, per pound of body weight; caloric tax, $1.77 per pound of body weight).
The greatest net benefit is for a tax on total calories, which is to be expected since that tax is more directly targeted on the source of the problem, an energy surplus. As the authors note, these results might understate the effectiveness of the tax instrument since they did not allow for 22 Many of these policy options, like R&D, are not directly targeted on the economic distortion associated with obesity (mainly in excess costs of health care provision), and may be ineffective or inefficient for that reason. The issue becomes one of comparative effectiveness and efficiency of suboptimal policies in an n th -best world.
changes in food manufacturing to adapt to the taxes, and any such taxes would be regressive on the poor.
Alston, Okrent, and Parks (2013) primarily to changes in technology-but not so much to changes in farming technology that contributed to the abundance of farm commodities used to make food, as to the development and adoption of labor-saving technology used to prepare food and the concomitant rise of massprepared food. 23 Other technological innovations-e.g., in telecommunications and public and private transportation-may also have contributed by encouraging reduced physical activity.
Would anyone seriously propose reverting to the 1970s technologies used at home and by industry in producing and preparing and processing food, and in every other aspect of our daily lives, with a view to saving the excess social costs attributed to the increase in prevalence of overweight and obesity among Americans? Perhaps some true zealots may state such a position, even if they choose not to reject all modern technologies in their personal lives. But such a policy would be extraordinarily expensive for the economy as a whole and would be regressive on the poor.
What is the appropriate policy? In light of the arguments and evidence presented here, it would seem to be appropriate to have an R&D policy that emphasized reducing distortions in research investments and worked towards maximizing net social benefits from research, and to use other instruments to tackle obesity-perhaps including some appropriately targeted food taxes as part of the policy set. Allowing for the presence of other economic distortions in the economy, as they influence the net social returns to different types of research investments,
should not have large implications for the optimal research portfolio (see Alston, Edwards and Freebairn 1988, and Alston 1994 ). Although we do not have detailed comparable empirical evidence of the same type related to the trade-offs involved in using agricultural research to achieve other types of social objectives, we suspect the findings will be similar in general-the rationale is conceptual, not empirical.
Conclusion
It is appropriate to be concerned with recent trends in agricultural R&D policy for several reasons. First, by all indications available to us, the world is spending too little on agricultural R&D in total, and too little on certain types of agricultural R&D where institutions do not encourage private investment and governments have not sufficiently corrected the problem. As documented by Pardey, Alston, and Chan-Kang (2013) , the world table is shifting with a rising role of the middle-income countries, a shrinking role of the high-income countries, and a continuing neglect in the poorest countries that may be the relevant focus of much of what we have discussed in this paper. Second, the scarce resources that are being made available for public agricultural research are increasingly being asked to serve a multitude of masters for which they may be little suited. In many places "agricultural" research resources are being diverted away from productivity enhancing research in farming and food production to pursue environmental, nutritional, health, or income distributional targets. In many instances, agricultural research will be an ineffective instrument for pursuing the target in question and, even if effective, it will usually not be the least-cost means for the job.
In this paper we have sought to elucidate to aspects of this situation. First, we have compiled a variety of measures that are suggestive of the view that agricultural R&D, directed at increasing the general abundance of food, generates a very large net social benefit while at the same time yielding great benefits for the health and well-being of the poor. Given the great and persistent underinvestment in productivity-enhancing agricultural R&D, as in the Green Revolution, we can continue to do much good for the poor while doing well for the economy as a whole simply by investing in those agricultural research areas where the total payoff will be highest. Second, as illustrated by the example of using agricultural R&D policy as obesity policy in the United States, the available empirical evidence indicates that it can be very counterproductive to seek to use public agricultural research as an instrument of social policy rather than using it as an instrument for correcting market failures in agricultural science.
Of course, the world is a much more complex place than our simple analytics can convey.
In many places even second-best solutions will be far beyond the reach of practical policy. In the political reality of agricultural science funding, it will continue to be better to accept funding conditional on it being used for a particular-lower payoff-purpose if the alternative is to have an even worse problem of underinvestment in the total portfolio. Even so, having to compromise some of the time does not mean we should passively make the same kinds of choices when not constrained to do so given that the research portfolio that maximizes total net benefits from the investment stands a good chance of being the one that also yields the greatest benefits for the poor, their health, and their life expectancies.
Appendix A: Agricultural R&D as an instrument of social policy
Governments use a range of policy instruments to pursue a range of social objectives related to human health and wellbeing, poverty, food security, the environment, and so on. Since agricultural R&D can have consequences for many of the human outcomes that are represented in this broad policy agenda, it seems natural for policymakers to want to consider these consequences in setting priorities for public agricultural R&D. Indeed, some propose to target agricultural R&D to achieve particular social objectives-such as healthier diets, better environmental outcomes, or reduced poverty-perhaps on the (mistaken) grounds that agricultural productivity is not a concern or that food is already abundant.
Such thinking suffers from several economic flaws. First, the fundamental economic rationale for public agricultural R&D is to correct market failures, mainly in the form of underinvestment arising from inadequate private property rights to inventions. Any diversion of public research spending away from the allocation that maximizes net social benefits necessarily compromises the primary purpose and the social benefit from the investment necessarily falls.
Moreover, since we are grossly underinvesting in agricultural R&D, in spite of extensive government intervention, the opportunity cost of diverting agricultural funds to other purposes will be very high. Second, public agricultural R&D is not the only policy instrument available to the government. Other policies that are more closely targeted on particular social objectives are likely to be both more effective and more economically efficient than targeted agricultural R&D.
Moreover, the economic relationships between research investments and social and economic outcomes are complicated and not transparently obvious. Indeed, it is conceivable that R&D targeted on a particular social objective may be less effective and less efficient and may contribute less to that purpose than non-targeted R&D would.
These ideas are illustrated in Figure A -1, which represents trade-offs between "efficiency" (E) measured by total benefits and "equity" (V) measured by benefits to a particular group as a share of the total. In this figure, BTC R is the benefit-transformation curve for research that represents the combinations of efficiency and equity that could be attained by allocating different amounts of the total research budget to targeted research. Point a represents the attainable equity-efficiency combination that maximizes equity and point b represents the attainable combination that maximizes efficiency. Policymakers perceiving a trade-off between these two objectives as represented by the policy indifference curve, IC 0 , might choose the combination at point b (E*, V*). However, if some other policy instrument could be used in conjunction with agricultural R&D, the higher benefit-transformation curve BTC* would permit a greater quantity of both equity and efficiency, such as at point d (E**, V**) on IC 1 . The optimal solution could involve none of the research being targeted to equity, depending on the efficacy of the non-research instruments.
[ Figure Notes: All data pertain to the United States. The following commodities were included in the cereals average: barley, corn, oats, rice, rye, sorghum and wheat. To estimate an average yield for cereals, we divided the sum of the quantity produced of each commodity by the coresponding sum of area harvested. To estimate a real price index for cereals, the respective annual series of commodity-specific nominal prices were first deflated by an index of prices received by farmers (base year 1961) developed by the authors using data from Gardner (2006) and USDA-NASS (2009 ). An index of real cereal prices was then formed by using the commodity specific value shares in the total value of cereal production as weights to aggregate the respective real price indexes for each of the included commodities. Source: Developed by the authors using data from Johansson and Lindgren (2013) .
Note:
The regional average life-expectancies plotted here were formed as weighted averages of the country-specific average life-expectancies, where the weights were the respective population shares of countries within their regions. Source: Developed by the authors using data from Johansson and Lindgren (2013) .
Note: The sizes of the circles indicate the respective countries' shares of global population. 
